Webinar from the Food and Drug Administration: Cannabis and Cannabis-Derived Products
The Food and Drug Administration (FDA) will hold an educational webinar on cannabis and cannabis-derived products for healthcare practitioners in late March.
The Food and Drug Administration (FDA) will hold an interactive and educational webinar on cannabis as part of its Division of Drug Information in the Center for Drug Evaluation and Research (CDER) series of webinars (1). The webinars are intended for health care professionals and students, physicians, physician assistants, nurses, pharmacists, and pharmacy technicians with the goal of learning about the FDA and drug regulation (1).
The webinar, which will be presented on Tuesday, March 28, 2023 at 10:00am PDT, is called “FDA Drug Topics: Cannabis and Cannabis-Derived Products–For Healthcare Practitioners” and is presented by CDER’s Office of Communication, Division of Drug Information (DDI).
“This webinar will provide a general understanding of the Cannabis sativa L. plant and how products are generally produced utilizing cannabis raw materials,” states the description (1). “The presentation will explain why manufacturing controls surrounding cannabis and cannabis-derived products are an integral part of protecting the public health. Will provide attendees with greater knowledge of the many products available on the marketplace, a discussion on potential benefits and risks, ways to report adverse events associated with these products to FDA, as well as suggestions on how to create a safe space to discuss patient use of these products.”
“The recording of the webinar will be available on our Division of Drug Information Webinars webpage later this week and will also be available as a Home Study course providing CE credit in a few weeks,” the announcement also stated (1,2).
Register here for the webinar.
References
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
